Algorithms and working party guidelines

Guidelines algorithms are developed for healthcare professionals working in primary and shared care. They are put together by clinical experts to meet a clinical need that is not currently covered by national guidance. Items may contain pharmaceutical promotional information.

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.

Guideline for the managed introduction of biosimilar basal insulin

By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

Medication management of patients with enteral feeding tubes

By Working party—Wright Griffith Merriman Smithard Smyth Welsh

This guideline was developed by a multidisciplinary expert panel: Wright D et al with the support of a grant from Rosemont Pharmaceuticals Ltd.

Uncomplicated recurrent UTI guideline

By Working party—Rees Brocksom Harding Jacobson Rollinson

This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from a pharmaceutical company.

Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment

Commissioned by Bayer plc

This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.

Stable peripheral arterial disease guideline

By Working party—Begg Antoniou Fay Garnham Nuttall

This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.

Stable coronary artery disease guideline

By Working party—Fay Banerjee Begg Bostock-Cox Gordon

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.

Pancreatic exocrine insufficiency guideline

By Development group: Hambling Cummings Merriman & Widdowson

This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.

Swallowing difficulties: management in adults with learning disability

By Working Party—Wright et al.

This helpful guideline summary on the identification and management of dysphagia in adults with learning disabilities includes a referral pathway algorithm.

Use of unlicensed medicines in paediatric patients guideline

By Working Party—Tomlin Cockerill Costello Griffith Hicks Sutcliffe Tuleu Wong Wright

A clear and concise summary of guidance for the safe prescribing of unlicensed medicines in paediatric patients. Includes legal guidance for prescribers.

Swallowing difficulties: medication management guideline

By Working Party—Wright Begent Crawford Foundling-Miah Griffith & Merriman

A concise guideline summary for the identification and management of adults with swallowing difficulties, including an updated management algorithm for choosing appropriate routes of administration

Management of BPH with LUTS guideline

By Development Group: Rees Brocksom Garner & Rochester

This management algorithm was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from NeoTract, Inc.

Inhaler choice guideline

By Development group: Usmani Capstick Chowhan and Scullion

A useful and informative algorithm for choosing an appropriate inhaler device for the treatment of adults with asthma or COPD.